We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALA market cap is 215.28M. The company's latest EPS is AUD -0.0083 and P/E is -24.10.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 676k | 1.16M | 296k | 1.45M | 1.95M |
Operating Income | -10.61M | -4.81M | -8.43M | -10.19M | -8.88M |
Net Income | -9.94M | -5.05M | -8.62M | -10.18M | -8.75M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 6.71M | 10.69M | 9.21M | 5.47M | 13.29M |
Total Liabilities | 2.57M | 1.71M | 1.6M | 1.69M | 2.06M |
Total Equity | 4.14M | 8.98M | 7.62M | 3.78M | 11.23M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -2.88M | -3.55M | -6.27M | -6.4M | -6.91M |
Investing | -388k | -514k | -566k | 95k | -179k |
Financing | -64k | 9.8M | 6.19M | 5.41M | 14.61M |
Market Cap | 215.28M |
Price to Earnings Ratio | -24.10 |
Price to Sales Ratio | 105.26 |
Price to Cash Ratio | 16.53 |
Price to Book Ratio | 18.71 |
Dividend Yield | - |
Shares Outstanding | 1.05B |
Average Volume (1 week) | 2.19M |
Average Volume (1 Month) | 1.74M |
52 Week Change | 95.24% |
52 Week High | 0.21 |
52 Week Low | 0.08 |
Spread (Intraday) | 0.01 (2.44%) |
Company Name | Arovella Therapeutics Ltd |
Address |
level 3 melbourne, victoria 3053 |
Website | https://www.sudapharma.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions